Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

The impact of the COVID-19 pandemic on antimicrobial usage: An international patient-level cohort study

Farzana R. et al, (2025), JAC-Antimicrobial Resistance, 7

Multi-antigen serology and a diagnostic algorithm for the detection of arbovirus infections as novel tools for arbovirus preparedness in southeast Europe (MERMAIDS-ARBO): a prospective observational study

Kasbergen LMR. et al, (2025), The Lancet Infectious Diseases

Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational study

Sigfrid L. et al, (2025), The Lancet Infectious Diseases

Utilising primary care electronic health records to deliver the ALABAMA randomised controlled trial of penicillin allergy assessment

Ahmed S. et al, (2024), Trials, 25

Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiology

Martin NG. et al, (2024), Journal of Infection, 88

Evaluating the Impact of the BioFire FilmArray in Childhood Meningitis: An Observational Cohort Study.

Kadambari S. et al, (2024), Pediatr Infect Dis J

Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children

Kazmin D. et al, (2023), npj Vaccines, 8

Penicillin allergy status and its effect on antibiotic prescribing, patient outcomes and antimicrobial resistance (ALABAMA): protocol for a multicentre, parallel-arm, open-label, randomised pragmatic trial

Armitage KF. et al, (2023), BMJ Open, 13

AN EARLY CLINICAL PHASE COMPARISON OF AN AUTOMATED VR COGNITIVE THERAPY WITH VR MENTAL RELAXATION THERAPY FOR THE TREATMENT OF PERSISTENT PERSECUTORY DELUSIONS IN PATIENTS DIAGNOSED WITH PSYCHOSIS (THRIVE): A PARALLEL GROUP, SINGLE-BLIND, RANDOMISED CONTROLLED TRIAL IN ENGLAND WITH MEDIATION ANALYSES.

FREEMAN D., (2023), Lancet Psychiatry

Dietary Approaches to the Management Of type 2 Diabetes (DIAMOND) in primary care: A protocol for a cluster randomised trial

Scragg J. et al, (2023), Contemporary Clinical Trials, 129

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Butler CC. et al, (2023), The Lancet, 401, 281 - 293

Automated virtual reality cognitive therapy versus virtual reality mental relaxation therapy for the treatment of persistent persecutory delusions in patients with psychosis (THRIVE): a parallel-group, single-blind, randomised controlled trial in England with mediation analyses

Freeman D. et al, (2023), The Lancet Psychiatry

Agoraphobic avoidance in patients with psychosis: Severity and response to automated VR therapy in a secondary analysis of a randomised controlled clinical trial

Freeman D. et al, (2022), Schizophrenia Research, 250, 50 - 59

Mixed-methods evaluation of a behavioural intervention package to identify and amend incorrect penicillin allergy records in UK general practice

Wanat M. et al, (2022), BMJ open, 12

Effect of Self-monitoring of Blood Pressure on Blood Pressure Control in Pregnant Individuals with Chronic or Gestational Hypertension: The BUMP 2 Randomized Clinical Trial

Chappell LC. et al, (2022), JAMA, 327, 1666 - 1678

Virtual reality (VR) therapy for patients with psychosis: satisfaction and side effects.

Freeman D. et al, (2022), Psychol Med, 1 - 12

Automated virtual reality (VR) therapy (gameChange) treating agoraphobic avoidance and distress in patients with psychosis: a multicentre, parallel group, single-blind, randomised controlled trial in England with mediation and moderation analyses

FREEMAN D. and FREEMAN D., (2022), Lancet Psychiatry

Molnupiravir Plus Usual Care Versus Usual Care Alone as Early Treatment for Adults with COVID-19 at Increased Risk of Adverse Outcomes (PANORAMIC): Preliminary Analysis from the United Kingdom Randomised, Controlled Open-Label, Platform Adaptive Trial

Butler C. et al, (2022)

Testing the short-term effectiveness of primary care referral to online weight loss programmes: A randomised controlled trial.

Noreik M. et al, (2021), Clin Obes

The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): A double-blind randomised placebo-controlled trial

Wang K. et al, (2021), European Respiratory Journal, 58

Load More